B. Advertorial, “Advertorial: EMA REAFFIRMS POSITIVE BENEFIT-RISK BALANCE OF BAYER’S XARELTO® FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION”, SAHJ, vol. 13, no. 1, pp. 42–43, Mar. 2017.